Xinghua Huang1, Guoqing Ji, Yanhua Wu, Bo Wan, Long Yu. 1. The State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, No. 220 Handan Road, Shanghai 200433, People's Republic of China.
Abstract
PURPOSE: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in China. Hepatocarcinogenesis is correlated with a series of gene expression alteration. Here, we investigated LAMA4 gene expression in hepatocellular carcinoma on both mRNA and protein levels, expecting to explore the relationship between expressional abundances of LAMA4 and the clinical characteristics of HCC specimens. METHOD: Total RNA was extracted from 48 cases of surgically resected HCC specimens and their corresponding peripheral tumor-free liver tissues. After the optimal reverse transcription polymerase chain reaction condition was established, the mRNA levels of LAMA4 in tumor and peripheral tumor-free tissues were examined semi-quantitatively. The relationship between expression levels of LAMA4 and clinical pathological characteristics was further analyzed by two-tailed t-test and chi2 test. We also used anti-LAMA4 antibody to detect the in vivo distribution of LAMA4 protein by tissue immunofluorescence staining in HCC specimens and their peripheral tumor-free tissues. RESULTS: The expression level of LAMA4 in 48 cases of human hepatocellular carcinoma tissues was significantly higher than that in their corresponding peripheral tumor-free tissues (0.37 +/- 0.25 vs. 0.18 +/- 0.12, P < 0.01). LAMA4 gene was up-regulated in 30 (62.50%) cases of HCC, down regulated in 4 (8.33%) cases, and showed no significant changes in 14 (29.17%) cases. Analysis of relationship between LAMA4 gene expression abundances and clinical characteristics by chi2 test showed that up-regulation of LAMA4 was strongly correlated with tumor invasion (79.31%), incomplete or no envelope (75.00%) and tumor bolt (86.67%). Additionally, tissue immunofluorescence staining against LAMA4 protein detected strong signal only in HCC tissues but not their corresponding peripheral tumor-free liver tissues. To our attention, LAMA4 protein showed specific in vivo distribution along the basement membrane of tumor blood vessels, bringing insights into its potential role in tumor angiogenesis. CONCLUSIONS: LAMA4 is specifically up-regulated on both mRNA and protein levels in hepatocelluar carcinoma. The strong correlation between high expression abundances of LAMA4 with tumor invasion and metastasis, as well as, LAMA4 specific in vivo distribution in tumor basement membrane, indicated LAMA4's potential role in hepatocarcinogenesis and tumor progression. Therefore, we hypothesize that LAMA4 is probably a novel supplementary marker for HCC diagnosis, and might be a molecular target in the future cancer therapy.
PURPOSE:Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in China. Hepatocarcinogenesis is correlated with a series of gene expression alteration. Here, we investigated LAMA4 gene expression in hepatocellular carcinoma on both mRNA and protein levels, expecting to explore the relationship between expressional abundances of LAMA4 and the clinical characteristics of HCC specimens. METHOD: Total RNA was extracted from 48 cases of surgically resected HCC specimens and their corresponding peripheral tumor-free liver tissues. After the optimal reverse transcription polymerase chain reaction condition was established, the mRNA levels of LAMA4 in tumor and peripheral tumor-free tissues were examined semi-quantitatively. The relationship between expression levels of LAMA4 and clinical pathological characteristics was further analyzed by two-tailed t-test and chi2 test. We also used anti-LAMA4 antibody to detect the in vivo distribution of LAMA4 protein by tissue immunofluorescence staining in HCC specimens and their peripheral tumor-free tissues. RESULTS: The expression level of LAMA4 in 48 cases of humanhepatocellular carcinoma tissues was significantly higher than that in their corresponding peripheral tumor-free tissues (0.37 +/- 0.25 vs. 0.18 +/- 0.12, P < 0.01). LAMA4 gene was up-regulated in 30 (62.50%) cases of HCC, down regulated in 4 (8.33%) cases, and showed no significant changes in 14 (29.17%) cases. Analysis of relationship between LAMA4 gene expression abundances and clinical characteristics by chi2 test showed that up-regulation of LAMA4 was strongly correlated with tumor invasion (79.31%), incomplete or no envelope (75.00%) and tumor bolt (86.67%). Additionally, tissue immunofluorescence staining against LAMA4 protein detected strong signal only in HCC tissues but not their corresponding peripheral tumor-free liver tissues. To our attention, LAMA4 protein showed specific in vivo distribution along the basement membrane of tumor blood vessels, bringing insights into its potential role in tumor angiogenesis. CONCLUSIONS:LAMA4 is specifically up-regulated on both mRNA and protein levels in hepatocelluar carcinoma. The strong correlation between high expression abundances of LAMA4 with tumor invasion and metastasis, as well as, LAMA4 specific in vivo distribution in tumor basement membrane, indicated LAMA4's potential role in hepatocarcinogenesis and tumor progression. Therefore, we hypothesize that LAMA4 is probably a novel supplementary marker for HCC diagnosis, and might be a molecular target in the future cancer therapy.
Authors: R E Burgeson; M Chiquet; R Deutzmann; P Ekblom; J Engel; H Kleinman; G R Martin; G Meneguzzi; M Paulsson; J Sanes Journal: Matrix Biol Date: 1994-04 Impact factor: 11.583
Authors: C C Hsia; D E Kleiner; C A Axiotis; A Di Bisceglie; A M Nomura; G N Stemmermann; E Tabor Journal: J Natl Cancer Inst Date: 1992-11-04 Impact factor: 13.506
Authors: Tal Teitz; Madoka Inoue; Marcus B Valentine; Kejin Zhu; Jerold E Rehg; Wei Zhao; David Finkelstein; Yong-Dong Wang; Melissa D Johnson; Christopher Calabrese; Marcelo Rubinstein; Razqallah Hakem; William A Weiss; Jill M Lahti Journal: Cancer Res Date: 2013-03-27 Impact factor: 12.701
Authors: Joseph W Wragg; Jonathan P Finnity; Jane A Anderson; Henry J M Ferguson; Emilio Porfiri; Rupesh I Bhatt; Paul G Murray; Victoria L Heath; Roy Bicknell Journal: Cancer Res Date: 2016-02-26 Impact factor: 12.701